Related Experiment Videos
Extra-renal non-cerebral rhabdoid tumours
Franck Bourdeaut1, Paul Fréneaux, Bénédicte Thuille
1Institut Curie, Departement de Pediatrie, Paris, France. franck.bourdeaut@curie.net
Pediatric Blood & Cancer
|May 29, 2008
Summary
Extra-renal non-cranial rhabdoid tumors (ERRTs) in children share the aggressive characteristics of other rhabdoid tumors. These rare pediatric cancers exhibit early recurrence and a poor prognosis, with no chemotherapy regimen showing superior efficacy.
Area of Science:
- Pediatric Oncology
- Cancer Biology
- Tumorigenesis
Background:
- Rhabdoid tumors (RTs) are aggressive pediatric malignancies primarily affecting the kidney and brain.
- Extra-renal non-cranial RTs (ERRTs) represent a rare but significant subset of these tumors.
- Understanding ERRTs is crucial for improving outcomes in affected children.
Purpose of the Study:
- To conduct a national, multi-center retrospective analysis of extra-renal non-cranial rhabdoid tumors (ERRTs).
- To characterize the clinical presentation, treatment, and outcomes of ERRTs.
- To compare the characteristics of ERRTs with those of renal and cerebral RTs.
Main Methods:
- Diagnosis confirmed by central histological review and/or hSNF5/INI1 defect analysis (immunohistochemistry or molecular screening).
- Retrospective collection of clinical data from treating physicians.
- Analysis of treatment modalities including surgery, chemotherapy, and radiotherapy.
Main Results:
- Twenty-six patients met the inclusion criteria for ERRTs, with a median age at diagnosis of 28 months.
- Complete surgical resection was achieved in only three patients.
- Chemotherapy was administered to most patients, with variable regimens; radiotherapy was used in six.
- Median time to recurrence or progression was 5 months, with one patient disease-free at 7 years.
Conclusions:
- ERRTs exhibit similar chemosensitivity, early recurrence patterns, and poor prognosis as renal and cerebral RTs.
- Current chemotherapy regimens do not demonstrate a superior response in ERRTs.
- Further research is needed to identify more effective therapeutic strategies for ERRTs.
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:21Smooth Endoplasmic Reticulum
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...